Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Medical Devices

Medical Device Use in the Home Environment Guidance Workshop, May 24, 2010 - Breakout Session Notes: Post Market

Facilitator: Susan Gardner FDA
Scribe: Janette Collins-Mitchell

  • Audience: Mostly Industry

How can we capture information about devices not he market to minimize hazards?

  • What can industry do to improve devices on the postmarket end
  • How to monitor the safety of devices in the home
    • Connect to all customer
  • Specific steps to monitor device safety in the home
    • Sign-up track software for defect
    • Create avenue to secure good quality data
    • Communicate AEs to manufacturers
  • FDA should determine the group that can provide quality data
    • Issues of daily living is magnified with devices in the home
  • FDA to make clear when to report and what to report, who should report and when to report
  • The quality of the report can be influenced by
    • Missing information (i.e. consumer ID; detail of instrument operation and the problem)
    • The consumers’ only concern is their disease not the function of the device
    • Consumer lack of knowledge of HIPPA reporting
  • Guidance should highlight different avenue to get information to patients
    • Regulatory
    • Home Health Agencies
    • Labeling
    • Trained healthcare providers––define and specify training necessary
  • Electronic Reporting
    • Permanent not on Serial number
    • True outcome
    • Establish early baseline
    • Provide data log to track for trending; can be reconstructed to access more information
  • UDI––complete the tracking of product from manufacturer to patient
  • FDA assumption is that all devices will eventually migrate into the home

Page Last Updated: 04/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.